Hemostemix   Report issue

For profit Phase 2
Founded: Blackfalds AB Canada (2006)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2014
NCT02551679
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Hemostemix Inc.